Nutrition Throughout the Treatment Course - Expanding Care From Hospital to Home - Trial NCT05997329
Access comprehensive clinical trial information for NCT05997329 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Oslo and is currently Not yet recruiting. The study focuses on Head and Neck Cancer. Target enrollment is 125 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Oslo
Timeline & Enrollment
N/A
Nov 01, 2023
Dec 31, 2025
Primary Outcome
Malnutrition
Summary
Patients with cancer have increased risk of malnutrition due to the disease itself and the
 treatment regimen they undergo. This is particularly relevant for patients with head and neck
 cancer (HNC), where 74%-95% are malnourished. HNC is a heterogenous group of cancers,
 including oral cavity, larynx, pharynx and salivary glands. The present project will study
 the effectiveness and implementation of remote patient monitoring of nutrition and tailored
 nutrition support throughout the treatment course in patients with head and neck cancer. The
 implementation will be evaluated in a randomized controlled trial (RCT), and the aim of the
 project is to reduce the prevalence of malnutrition and increase the quality of life among
 patients with HNC.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05997329
Non-Device Trial